Quick Answer
Moderna, Inc. reported Revenue (ASC 606) of $1.94 billion for fiscal year 2025.
Moderna, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $1.94B | -39.9% |
| 2024 | $3.24B | -52.7% |
| 2023 | $6.85B | -64.4% |
| 2022 | $19.26B | +4.3% |
| 2021 | $18.47B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.02B | -45.4% | +615.5% |
| June 30, 2025 | $142.00M | -41.1% | +31.5% |
| March 31, 2025 | $108.00M | -35.3% | -94.2% |
| September 30, 2024 | $1.86B | +1.7% | +672.6% |
| June 30, 2024 | $241.00M | -29.9% | +44.3% |
| March 31, 2024 | $167.00M | -91.0% | -90.9% |
| September 30, 2023 | $1.83B | -45.6% | +432.3% |
| June 30, 2023 | $344.00M | — | -81.5% |
- Moderna, Inc. showed a decrease of -39.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2021–2025 period, Moderna, Inc.’s revenue (asc 606) has declined by 89.5% (from $18.47 billion to $1.94 billion).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: